216 related articles for article (PubMed ID: 23401854)
1. P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.
Zhang Y; Saporita AJ; Weber JD
Mol Cell Biol; 2013 Apr; 33(8):1594-607. PubMed ID: 23401854
[TBL] [Abstract][Full Text] [Related]
2. Identification of DHX33 as a mediator of rRNA synthesis and cell growth.
Zhang Y; Forys JT; Miceli AP; Gwinn AS; Weber JD
Mol Cell Biol; 2011 Dec; 31(23):4676-91. PubMed ID: 21930779
[TBL] [Abstract][Full Text] [Related]
3. The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation.
Kuchenreuther MJ; Weber JD
Oncogene; 2014 Jan; 33(3):300-7. PubMed ID: 23318441
[TBL] [Abstract][Full Text] [Related]
4. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
5. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
6. The DHX33 RNA Helicase Promotes mRNA Translation Initiation.
Zhang Y; You J; Wang X; Weber J
Mol Cell Biol; 2015 Sep; 35(17):2918-31. PubMed ID: 26100019
[TBL] [Abstract][Full Text] [Related]
7. Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.
Miceli AP; Saporita AJ; Weber JD
Mol Cell Biol; 2012 Jan; 32(2):348-64. PubMed ID: 22064482
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.
Saporita AJ; Chang HC; Winkeler CL; Apicelli AJ; Kladney RD; Wang J; Townsend RR; Michel LS; Weber JD
Cancer Res; 2011 Nov; 71(21):6708-17. PubMed ID: 21937682
[TBL] [Abstract][Full Text] [Related]
9. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
[TBL] [Abstract][Full Text] [Related]
10. TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.
Pelletier CL; Maggi LB; Brady SN; Scheidenhelm DK; Gutmann DH; Weber JD
Cancer Res; 2007 Feb; 67(4):1609-17. PubMed ID: 17308101
[TBL] [Abstract][Full Text] [Related]
11. DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers.
Nie G; Chen S; Song Q; Zou D; Li M; Tang X; Deng Y; Huang B; Yang M; Lv G; Zhang Y
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130547. PubMed ID: 38143011
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of p68 RNA Helicase (DDX5) Activates a Survival Pathway Involving mTOR and MDM2 Signals.
Kokolo M; Bach-Elias M
Folia Biol (Praha); 2017; 63(2):52-59. PubMed ID: 28557706
[TBL] [Abstract][Full Text] [Related]
13. The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition.
Wang H; Yu J; Wang X; Zhang Y
Cell Signal; 2019 Feb; 54():170-178. PubMed ID: 30552990
[TBL] [Abstract][Full Text] [Related]
14. Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo.
Wang X; Feng W; Peng C; Chen S; Ji H; Zhong H; Ge W; Zhang Y
Cancer Sci; 2020 Oct; 111(10):3564-3575. PubMed ID: 32767810
[TBL] [Abstract][Full Text] [Related]
15. Role of DHX33 in c-Myc-induced cancers.
Fu J; Liu Y; Wang X; Yuan B; Zhang Y
Carcinogenesis; 2017 Jun; 38(6):649-660. PubMed ID: 28498893
[TBL] [Abstract][Full Text] [Related]
16. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
18. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.
Sreeramaneni R; Chaudhry A; McMahon M; Sherr CJ; Inoue K
Mol Cell Biol; 2005 Jan; 25(1):220-32. PubMed ID: 15601844
[TBL] [Abstract][Full Text] [Related]
19. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
